Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) — Financial Flexibility Index
Eupraxia Pharmaceuticals Inc. Common Stock (EPRX) has a Financial Flexibility Index of -0.82x as of September 2025. Free cash flow of $-4.45 Million (operating CF $-4.51 Million minus capex $60.38K) represents -1% of total liabilities ($5.43 Million). Check how resilient are Eupraxia Pharmaceuticals Inc. Common Sto's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eupraxia Pharmaceuticals Inc. Common Stock Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Eupraxia Pharmaceuticals Inc. Common Stock across 8 annual periods. See Eupraxia Pharmaceuticals Inc. Common Sto short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Eupraxia Pharmaceuticals Inc. Common Stock (2017–2024)
Year-by-year free cash flow to debt coverage for Eupraxia Pharmaceuticals Inc. Common Stock. For the full company profile including market capitalisation, see EPRX market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.63x | $-29.89 Million | $-29.99 Million | $3.10 Million | ▼ -802.5% |
| 2023 | -1.07x | $-20.68 Million | $-20.75 Million | $19.37 Million | ▼ -21.6% |
| 2022 | -0.88x | $-14.16 Million | $-14.40 Million | $16.13 Million | ▲ +5.4% |
| 2021 | -0.93x | $-11.23 Million | $-11.58 Million | $12.10 Million | ▼ -5213.8% |
| 2020 | -0.02x | $-403.78K | $-403.78K | $23.12 Million | ▲ +92.8% |
| 2019 | -0.24x | $-5.16 Million | $-5.17 Million | $21.42 Million | ▲ +57.7% |
| 2018 | -0.57x | $-8.18 Million | $-8.32 Million | $14.34 Million | ▲ +91.6% |
| 2017 | -6.77x | $-4.98 Million | $-5.30 Million | $735.82K | — |